News

Filter

Current filters:

Indinavir Sulfate

1 to 9 of 106 results

Merck & Co cuts HIV AIDS drug prices 22%

20-03-2006

Five years after the launch of its global HIV/AIDS drug pricing policy, USA-based drug major Merck &…

CrixivanEfavirenzIndinavir SulfateMerck KGaASustiva

Tipranavir more effective than lopinavir in HIV, study finds

07-03-2005

New data from multiple analyses presented at the Conference on Retroviruses and Opportunistic Infections…

Abbott LaboratoriesAptivusBoehringer IngelheimCrixivanGlaxoSmithKlineGSKIndinavir SulfateInviraseMerck KGaARocheSaquinavir MesylateTipranavir

MaxCmin 1 trial in favor of saquinavir

15-07-2002

The final results of the 317-patient MaxCmin 1 trial comparing two"boosted" HIV protease inhibitor regimens…

Abbott LaboratoriesCrixivanIndinavir SulfateMerck KGaARoche

CPMP backs new schedule for Roche HIV drug

24-06-2002

Europe's Committee for Proprietary Medicinal Products has granted apositive opinion for Roche's Invirase…

Abbott LaboratoriesCrixivanIndinavir SulfateInviraseMerck KGaANorvirOral SolutionRitonavir CapsulesRocheSaquinavir Mesylate

Brazil to step up HIV/ AIDS vaccine R&D

14-01-2002

Brazil plans to place greater emphasis on R&D into a vaccine forHIV/AIDS this year, and also to increase…

Abbott LaboratoriesCrixivanEfavirenzIndinavir SulfateMerck KGaAnelfinavirNorvirOral SolutionRitonavir CapsulesRocheSustivaViracept

1 to 9 of 106 results

Back to top